Particle.news

Download on the App Store

F

The pioneering cancer researcher is recovering after surgery to investigate changes in his brain, following his groundbreaking immunotherapy treatment.

Overview

  • Professor Richard Scolyer, a co-developer of revolutionary immunotherapy for melanoma, underwent complex brain surgery at Chris O'Brien Lifehouse in Sydney.
  • The surgery aimed to determine whether concerning changes detected in recent scans were due to his previous treatment or a recurrence of his glioblastoma.
  • Scolyer was diagnosed with terminal grade 4 glioblastoma in 2023 and became the first patient to receive his own immunotherapy treatment, which had shown remarkable results for melanoma.
  • The former Australian of the Year expressed gratitude to his medical team, family, and friends for their support and is now focused on recovery.
  • Scolyer's innovative approach to cancer treatment has extended his survival beyond initial expectations and continues to inform future brain cancer therapies.